Patients

Clinical trial screening visit readiness checklist for patients

A patient-friendly screening visit readiness checklist covering questions, records, logistics, communication, privacy, and study-team review.

Patients preparing for a clinical trial screening visit can organize questions, records, logistics, communication preferences, and privacy expectations before the study team reviews next steps.

In this guide

Key points

  • A screening visit is part of study-team review, not a guarantee of eligibility or enrollment.
  • Patients can prepare questions, logistics, medication and history notes, and records requested by the site.
  • Clear communication before the visit can reduce confusion about timing, location, and what to bring.

Confirm what the visit is for

A screening visit helps the authorized study team review whether the study may be appropriate under the protocol. It is not a guarantee that a patient is eligible, enrolled, or expected to continue.

Patients can ask what the screening visit may include, how long it may take, where it happens, and whether any remote steps need to be completed before arrival.

Prepare records and questions

If the site requests records, medication information, prior test information, or contact details for a provider, patients can gather those materials before the visit when possible. The site should explain what is needed and how to provide it securely.

Patients can write down questions about the study purpose, visit schedule, time commitment, reimbursement, privacy, communication preferences, and what happens after screening.

Check logistics before the appointment

Before the visit, confirm location, arrival time, parking or transit details, expected duration, contact number, and what to do if plans change. Hybrid studies may also require confirming a portal, link, device, or remote step.

If travel, scheduling, caregiver support, or language access may be difficult, patients can raise those concerns with the site before the appointment.

Know what happens after screening

After screening, the study team may need time to review information, request records, ask follow-up questions, or explain that the study is not the right fit. Patients can ask when to expect an update and who to contact with questions.

TrialsNest can help patients find study pages and organize early next steps, but the study team remains responsible for screening review, eligibility decisions, and enrollment decisions.

Sources and editorial notes

Published .

Patient education only. Screening visit instructions vary by study, site, and protocol.

This guide explains recruitment work and questions to discuss with your team.

TrialsNest does not provide medical advice, diagnosis, treatment, emergency care, or final study eligibility decisions. Authorized study teams review each study and applicant.

Study information

Have questions about taking part?

Review study information and ask the study team about visits, screening, and what happens next.

Keep reading